Cerity Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Sell |
28,764
-7,646
| -21% | -$68.5K | ﹤0.01% | 2229 |
|
|
2025
Q1 | $273K | Buy |
36,410
+24,418
| +204% | +$183K | ﹤0.01% | 2065 |
|
|
2024
Q4 | $90.5K | Sell |
11,992
-12,708
| -51% | -$95.9K | ﹤0.01% | 2344 |
|
|
2024
Q3 | $188K | Buy |
24,700
+13,066
| +112% | +$99.3K | ﹤0.01% | 2335 |
|
|
2024
Q2 | $71.9K | Sell |
11,634
-738
| -6% | -$4.56K | ﹤0.01% | 2144 |
|
|
2024
Q1 | $62.8K | Buy |
+12,372
| New | +$62.8K | ﹤0.01% | 2239 |
|